Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-26 @ 6:15 PM
Study NCT ID:
NCT07121959
Status:
COMPLETED
Last Update Posted:
2025-10-15
First Post:
2025-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2025-08-12
First Submit QC Date:
None
Study First Post Date:
2025-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-14
Last Update Post Date:
2025-10-15
Last Update Post Date Type:
ESTIMATED